Epidemiological studies indicate that amylin may be implicated in the intricate interplay between metabolic disturbances such as type 2 diabetes mellitus (T2DM) and neurodegenerative diseases, notably Alzheimer’s disease (AD) [36]. This evidence concerns the gene IAPP and type 2 diabetes mellitus.